Vaxxinity's cholesterol vaccine candidate successfully lowers ldl-c: preclinical data published

Preclinical data published in the journal of lipid research indicate vxx-401 is well-tolerated, with no safety signals observed, and robustly reduces ldl-c in cynomolgus monkeys.

VAXX Ratings Summary

VAXX Quant Ranking